Nasal Polyposis Drug Market
Global Nasal Polyposis Drug Market Size, Share, and Trends Analysis Report By Drug Class (Corticosteroids, Antibiotics, Leukotriene Inhibitors, and Others) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global nasal polyposis drug market is anticipated to grow at a significant CAGR of 6.5% during the forecast period 2022-2028. Nasal polyps develop as a result of persistent inflammation and are linked to asthma, recurrent infection, allergies, medication sensitivity, and some immunological disorders. The market is booming as the global prevalence of chronic sinusitis is rising. According to NCBI, in the general population, the prevalence of nasal polyps is considered to be around 4%. In cadaveric studies, this prevalence has been shown to be as high as 40%. They predominantly affect adults and are usually present in patients older than 20. Additionally, they are uncommon in children under 10 and maybe the presenting feature of cystic fibrosis. Up to a third of nasal polyps patients have asthma, whereas polyps are only found in 7% of asthmatics.
Impact of COVID-19 Pandemic on Global Nasal Polyposis Drug Market
The COVID-19 pandemic had a significant impact on the global nasal polyposis drug market owing to the COVID-19 infection in patients that can lead to the development of nasal polyps due to the consequences these drugs can be used to treat people suffering from COVID-19. Additionally, since the symptoms of COVID-19 and nasal polyps are quite similar, the nasal polyposis drug market also saw growth due to the impact of COVID-19, as people went for nasal polyps drugs for the treatment of nasal congestion, breathing problem, and many more.
Segmental Outlook
The global nasal polyposis drug market is segmented based on drug class and distribution channel. Based on the drug class, the market is sub-segmented into corticosteroids, antibiotics, leukotriene inhibitors, and others. Based on the distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
Global Nasal Polyposis Drug Market Share by Drug Class, 2021 (%)
The Corticosteroids Segment is Anticipated to Hold a Prominent Share in the Global Nasal Polyposis Drug Market
The corticosteroids segment is anticipated to hold the prominent share in the market due to the demand for corticosteroid drugs for the treatment of nasal polyps. The corticosteroid drug is offered in form of injection, intranasal sprays, and drops according to the need of the patient. The offering of various corticosteroids as topical formulations and aerosols, which have the capacity to reduce the size of nasal polyps and thereby heal them in patients, has also contributed to the market's considerable growth. Furthermore, as compared to other dose forms available on the market, patient compliance with creams is higher.
Regional Outlooks
The global nasal polyposis drug market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Some factors that are boosting the market growth in Asia-Pacific include growing prevalence of allergic disorders in region. Additionally, the existence of a large number of players providing effective offerings is some other main factor that is providing support to the growth of the market in the region.
Global Nasal Polyposis Drug Market Growth, by Region 2022-2028
The North America Region is Estimated to Hold the Major Share in the Global Nasal Polyposis Drug Market
The North American region is expected to hold a significant share in the global nasal polyposis drug market due to the rising incidence of various malignancies and allergy illnesses such as sinusitis. According to NCBI, chronic rhinosinusitis with nasal polyps (CRSwNP) accounts for 2-4% of the US population, affecting more than 5 million people in the country. Research activities in the US, together with higher regulatory approvals, are expected to boost the expansion of the global nasal polyposis drug market.
Market Players Outlook
GlaxoSmithKline PLC, Sanofi SA, Merck & Co. inc., and OptiNose US Inc. among others, are some of the key palyers in the global nasal polyposis drug market. To increase market share around the globe, these companies are using a variety of techniques, including mergers and acquisitions, product launches, geographic expansion and collaboration, and partnership. For instance, in August 2021, GlaxoSmithKline PLC announced the approval of Nucala (mepolizumab) from the FDA. It is used for the treatment of patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This new indication for mepolizumab is for the add-on maintenance treatment of CRSwNP in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global nasal polyposis drug market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global Nasal Polyposis Drug Market
- Recovery Scenario of Global Nasal Polyposis Drug Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Nasal Polyposis Drug Market by Drug Class
4.1.1. Corticosteroids
4.1.2. Antibiotics
4.1.3. Leukotriene Inhibitors
4.1.4. Others
4.2. Global Nasal Polyposis Drug Market by Distribution Channel
4.2.1. Hospital Pharmacy
4.2.2. Retail Pharmacy
4.2.3. Online Pharmacy
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AstraZeneca PLC
6.2. F. Hoffmann-La Roche Ltd.
6.3. GlaxoSmithKline PLC
6.4. Merck & Co. Inc.
6.5. Norton Waterford Ltd.
6.6. Novartis International AG
6.7. OptiNose US Inc.
6.8. Pfizer Inc.
6.9. Regeneron Pharmaceuticals Inc.
6.10. Sanofi SA
6.11. Teva Pharmaceutical Industries Ltd.
1. GLOBAL NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
2. GLOBAL CORTICOSTEROIDS NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL ANTIBIOTICS NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL LEUKOTRIENE INHIBITORS NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL OTHERS NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
7. GLOBAL HOSPITAL PHARMACY NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL RETAIL PHARMACY NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL ONLINE PHARMACY NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
13. NORTH AMERICAN NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
14. EUROPEAN NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. EUROPEAN NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
16. EUROPEAN NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
20. REST OF THE WORLD NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. REST OF THE WORLD NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
22. REST OF THE WORLD NASAL POLYPOSIS DRUG MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL NASAL POLYPOSIS DRUG MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL NASAL POLYPOSIS DRUG MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL NASAL POLYPOSIS DRUG MARKET, 2022-2028 (%)
4. GLOBAL NASAL POLYPOSIS DRUG MARKET SHARE BY DRUG CLASS, 2021 VS 2028 (%)
5. GLOBAL CORTICOSTEROIDS NASAL POLYPOSIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL ANTIBIOTICS NASAL POLYPOSIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL LEUKOTRIENE INHIBITORS NASAL POLYPOSIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL OTHERS NASAL POLYPOSIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL NASAL POLYPOSIS DRUG MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
10. GLOBAL HOSPITAL PHARMACY NASAL POLYPOSIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL RETAIL PHARMACY NASAL POLYPOSIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL ONLINE PHARMACY NASAL POLYPOSIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL NASAL POLYPOSIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. US NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
15. CANADA NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
16. UK NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
17. FRANCE NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
18. GERMANY NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
19. ITALY NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
20. SPAIN NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
21. REST OF EUROPE NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
22. INDIA NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
23. CHINA NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
24. JAPAN NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF THE ASIA-PACIFIC NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF THE WORLD NASAL POLYPOSIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
